#16_Attach_1_BBRB_SurveyQuestions

Questions for BBRB Study
ESBB Conference

Sections
1








Organizational structure (network / stand-alone)
Current funding sources
Scale of operations
Coverage of current and projected growth
Feedback on new potential funding sources
Current challenges

Copyright © HealthCare IT, Inc. 2012
All rights reserved

Organizational structure and governance
(network / stand-alone)
2


Is your biobank part of a:








What internal governance model oversees your biobank?







Healthcare provider
Clinical research organization
Drug or device developer
Commercial biobank
Other: ___________
Permanent steering committee
Ad-hoc steering committee
Scientific/pathologist oversight team
Other: ___________

Is your biobank part of a network?




If yes, does the network have a steering committee
Do you exchange samples within your network?
Does your institution receive funding from the network?

Copyright © HealthCare IT, Inc. 2012
All rights reserved

Current funding sources
3




What is your biobanks total annual budget?
What percentage of your budget comes from:









Charitable donations: ____
Support from our host enterprise: ____
Support from our network: ____
Grants: ____
Specimen sales: ____
Other: ____

What percentage is used for:




Labor/staffing: ____
Capital equipment: ____
Other operational expenses: ____

Copyright © HealthCare IT, Inc. 2012
All rights reserved

Scale of operations
4










How many full time staff? _____
How many FTE’s in part-time staff? _____
How many researchers do your support?
How many grants do you support?
What portion of grant funding goes to your bank?
How many samples in your bank?
How many samples do you add monthly?
What is the annual sample turn-over rate?

Copyright © HealthCare IT, Inc. 2012
All rights reserved

Coverage of current and projected growth
5



At what rate are your total costs increasing per year? ____ What is the
breakdown:







Labor: ____
Capital: ____
Other operational expenses: ____
(need clarifying instructions for these percentages)

At what rate are your funding sources changing (+/- percentage)







Charitable donations: ____
Support from our host enterprise: ____
Support from our network: ____
Grants: ____
Specimen sales: ____
Other: ____



Copyright © HealthCare IT, Inc. 2012
All rights reserved

Coverage of current and projected growth
6



At what rate are your total costs increasing per year? ____ What is
the breakdown:







Labor: ____
Capital: ____
Other operational expenses: ____
(need clarifying instructions for these percentages)

At what rate are your funding sources changing (+/- percentage)







Charitable donations: ____
Support from our host enterprise: ____
Support from our network: ____
Grants: ____
Specimen sales: ____
Other: ____

Copyright © HealthCare IT, Inc. 2012
All rights reserved

Feedback on new potential funding sources
7



How likely are you to initiate/increase each of the
following new/current sources:
New/Current; Highly likely, maybe, we will not pursue
 Charitable donations: ____
 Support from our host enterprise: ____
 Support from our network: ____
 Grants: ____
 Specimen sales: ____
 Other: ____

Copyright © HealthCare IT, Inc. 2012
All rights reserved

Current challenges
8


Please list the top three challenges that you are currently facing and/or anticipate
in the next 12 months:











1.
2.
3.

Sustaining current growth
Acquiring new specimens
Replacing declining funding sources
Keeping pace with quality standards
Labor attrition
Managing changing consent
Data security
Keeping pace with new informatics
Integrating our information systems
Centralizing biobank operations in my enterprise
Establishing a competitive pricing strategy/policy
____________
____________
____________

Copyright © HealthCare IT, Inc. 2012
All rights reserved